The objective is to perform a comprehensive review of the literature up to 2015 on the genetics and precision medicine relevant to otitis media.
Data Sources
PubMed database of the National Library of Medicine.
Review Methods
Two subpanels were formed comprising experts in the genetics and precision medicine of otitis media. Each of the panels reviewed the literature in their respective fields and wrote draft reviews. The reviews were shared with all panel members, and a merged draft was created. The entire panel met at the 18th International Symposium on Recent Advances in Otitis Media in June 2015 and discussed the review and refined the content. A final draft was made, circulated, and approved by the panel members.
Conclusion
Many genes relevant to otitis media have been identified in the last 4 years in advancing our knowledge regarding the predisposition of the middle ear mucosa to commensals and pathogens. Advances include mutant animal models and clinical studies. Many signaling pathways are involved in the predisposition of otitis media.
Implications for Practice
New knowledge on the genetic background relevant to otitis media forms a basis of novel potential interventions, including potential new ways to treat otitis media.
MacArthurCJHausmanFKemptonJBChoiDTruneDR.Otitis media impacts hundreds of mouse middle and inner ear genes. PLoS One. 2013;8:e75213.
2.
CasselbrantMLMandelEM.The genetics of otitis media. Curr Allergy Asthma Rep. 2001;1:353-357.
3.
RubenRJ.Otitis media: the application of personalized medicine. Otolaryngol Head Neck Surg. 2011;145:707-712.
4.
SibbaldAD.Acute otitis media in infants: the disease and the illness. Clinical distinctions for the new treatment paradigm. Otolaryngol Head Neck Surg. 2012;147:606-610.
5.
PichicheroMECaseyJRAlmudevarA.Reducing the frequency of acute otitis media by individualized care. Pediatr Infect Dis J. 2013;32:473-478.
6.
ZhangJXuMZhengQZhangYMaWZhangZ.Blocking macrophage migration inhibitory factor activity alleviates mouse acute otitis media in vivo. Immunol Lett. 2014;162:101-108.
7.
SuzukawaKTomlinJPakK. A mouse model of otitis media identifies HB-EGF as a mediator of inflammation-induced mucosal proliferation. PLoS One. 2014;9:e102739.
8.
KurabiALeeJWongC. The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media. Innate Immun. 2015;21:203-214.
9.
PreciadoDBurgettKGhimbovschiSRoseM.NTHi induction of Cxcl2 and middle ear mucosal metaplasia in mice. Laryngoscope. 2013;123:E66-E71.
10.
WooJIKilSHOhS. IL-10/HMOX1 signaling modulates cochlear inflammation via negative regulation of MCP-1/CCL2 expression in cochlear fibrocytes. J Immunol. 2015;194:3953-3961.
11.
WangWYKomatsuKHuangY. CYLD negatively regulates nontypeable Haemophilus influenzae–induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK. PLoS One. 2014;9:e112516.
12.
KomatsuKLeeJYMiyataM. Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD. Nat Commun. 2013;4:1684.
13.
HafrénLKentalaEEinarsdottirEKereJMattilaPS.Current knowledge of the genetics of otitis media. Curr Allergy Asthma Rep. 2012;12:582-589.
14.
HafrénLKentalaEJarvinenTM. Genetic background and the risk of otitis media. Int J Pediatr Otorhinolaryngol. 2012;76:41-44.
15.
AllenEKChenWMWeeksDE. A genome-wide association study of chronic otitis media with effusion and recurrent otitis media identifies a novel susceptibility locus on chromosome 2. J Assoc Res Otolaryngol. 2013;14:791-800.
16.
Rye MS, Scaman ES, Thornton RB, et al. Genetic and functional evidence for a locus controlling otitis media at chromosome 10q26.3. BMC Med Genet. 2014;15:18.
17.
SaleMMChenWMWeeksDE. Evaluation of 15 functional candidate genes for association with chronic otitis media with effusion and/or recurrent otitis media (COME/ROM). PLoS One. 2011;6:e22297.
18.
RyeMSWiertsemaSPScamanES. Genetic and functional evidence for a role for SLC11A1 in susceptibility to otitis media in early childhood in a Western Australian population. Infect Genet Evol. 2013;16:411-418.
19.
MacArthurCJWilmotBWangLSchullerMLighthallJTruneD.Genetic susceptibility to chronic otitis media with effusion: candidate gene single nucleotide polymorphisms. Laryngoscope. 2014;124:1229-1235.
20.
Nokso-KoivistoJChonmaitreeTJenningsKMatalonRBlockSPatelJA.Polymorphisms of immunity genes and susceptibility to otitis media in children. PLoS One. 2014;9:e93930.
21.
IliaSGoulielmosGNSamonisGGalanakisE.Polymorphisms in IL-6, IL-10, TNF-alpha, IFN-gamma and TGF-beta1 genes and susceptibility to acute otitis media in early infancy. Pediatr Infect Dis J. 2014;33:518-521.
22.
GessnerBDGillinghamMBWoodTKoellerDM.Association of a genetic variant of carnitine palmitoyltransferase 1A with infections in Alaska Native children. J Pediatr. 2013;163:1716-1721.
VuononvirtaJPeltolaVMertsolaJHeQ.Risk of repeated Moraxella catarrhalis colonization is increased in children with Toll-like receptor 4 Asp299Gly polymorphism. Pediatr Infect Dis J. 2013;32:1185-1188.
25.
HafrénLEinarsdottirEKentalaE. Predisposition to childhood otitis media and genetic polymorphisms within the Toll-like receptor 4 (TLR4) locus. PLoS One. 2015;10:e0132551.
26.
EspositoSMarchisioPOrentiA. Genetic polymorphisms of functional candidate genes and recurrent acute otitis media with or without tympanic membrane perforation. Medicine (Baltimore). 2015;94:e1860.
27.
RyeMSWarringtonNMScamanES. Genome-wide association study to identify the genetic determinants of otitis media susceptibility in childhood. PLoS One. 2012;7:e48215.
ShinSGKohSHWooCHLimJH.PAI-1 inhibits development of chronic otitis media and tympanosclerosis in a mouse model of otitis media. Acta Otolaryngol. 2014;134:1231-1238.
31.
YaoWFrieMPanJ. C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media. BMC Immunol. 2014;15:46.
32.
LiXXuLLiJ. Otitis media in sperm-associated antigen 6 (Spag6)-deficient mice. PLoS One. 2014;9:e112879.
33.
WooCHShinSGKohSHLimJH.TBX21 participates in innate immune response by regulating Toll-like receptor 2 expression in Streptococcus pneumoniae infections. Mol Oral Microbiol. 2014;29:233-243.
34.
NakamuraYKomoriMYamakawaK. Math1, retinoic acid, and TNF-alpha synergistically promote the differentiation of mucous cells in mouse middle ear epithelial cells in vitro. Pediatr Res. 2013;74:259-265.
35.
MaguireSEstabelJInghamN. Targeting of Slc25a21 is associated with orofacial defects and otitis media due to disrupted expression of a neighbouring gene. PLoS One. 2014;9:e91807.
36.
ChenJInghamNClareS. Mcph1-deficient mice reveal a role for MCPH1 in otitis media. PLoS One. 2013;8:e58156.
37.
TateossianHMorseSParkerA. Otitis media in the Tgif knockout mouse implicates TGFbeta signalling in chronic middle ear inflammatory disease. Hum Mol Genet. 2013;22:2553-2565.
38.
KerschnerJEHongWTaylorSR. A novel model of spontaneous otitis media with effusion (OME) in the Oxgr1 knock-out mouse. Int J Pediatr Otorhinolaryngol. 2013;77:79-84.
39.
HanFYuHLiP. Mutation in Phex gene predisposes BALB/c-Phex(Hyp-Duk)/Y mice to otitis media. PLoS One. 2012;7:e43010.
40.
ZhangYYuHXuM. Pathological features in the LmnaDhe/+ mutant mouse provide a novel model of human otitis media and laminopathies. Am J Pathol. 2012;181:761-774.
41.
TianCYuHYangB. Otitis media in a new mouse model for CHARGE syndrome with a deletion in the Chd7 gene. PLoS One. 2012;7:e34944.
42.
KuhnSInghamNPearsonS. Auditory function in the Tc1 mouse model of Down syndrome suggests a limited region of human chromosome 21 involved in otitis media. PLoS One. 2012;7:e31433.
43.
CheesemanMTTyrerHEWilliamsD. HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants. PLoS Genet. 2011;7:e1002336.
44.
HiltonJMLewisMAGratiM. Exome sequencing identifies a missense mutation in Isl1 associated with low penetrance otitis media in dearisch mice. Genome Biol. 2011;12:R90.
45.
YangBTianCZhangZG. Sh3pxd2b mice are a model for craniofacial dysmorphology and otitis media. PLoS One. 2011;6:e22622.
46.
LiQLiYXStahlGLThurmanJMHeYTongHH.Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice. Infect Immun. 2011;79:2578-2585.
47.
EbmeyerJLeichtleAHernandezM. TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media. BMC Immunol. 2011;12:12.
48.
LeichtleAHernandezMLeeJ. The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun. 2012;18:3-13.
49.
Noben-TrauthKLatocheJR.Ectopic mineralization in the middle ear and chronic otitis media with effusion caused by RPL38 deficiency in the Tail-short (Ts) mouse. J Biol Chem. 2011;286:3079-3093.
50.
WooJIPanHOhSLimDJMoonSK.Spiral ligament fibrocyte-derived MCP-1/CCL2 contributes to inner ear inflammation secondary to nontypeable H influenzae-induced otitis media. BMC Infect Dis. 2010;10:314.
51.
LeichtleAHernandezMEbmeyerJ. CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF-/- mice. J Immunol. 2010;184:3087-3097.
52.
LeichtleAHernandezMPakK. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media. Innate Immun. 2009;15:205-215.
53.
TateossianHHardisty-HughesREMorseS. Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant. Pathogenetics. 2009;2:5.
54.
HernandezMLeichtleAPakK. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. J Infect Dis. 2008;198:1862-1869.
55.
ShimadaJMoonSKLeeHY. Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media. BMC Infect Dis. 2008;8:134.
56.
DepreuxFFDarrowKConnerDA. Eya4-deficient mice are a model for heritable otitis media. J Clin Invest. 2008;118:651-658.
57.
Hardisty-HughesRETateossianHMorseSA. A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse. Hum Mol Genet. 2006;15:3273-3279.
58.
ParkinsonNHardisty-HughesRETateossianH. Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media. PLoS Genet. 2006;2:e149.
59.
TianCHarrisBSJohnsonKR. Ectopic mineralization and conductive hearing loss in Enpp1asj mutant mice, a new model for otitis,media and tympanosclerosis. PLoS One. 2016;11:e0168159.
60.
MitchellCRKemptonJBScott-TylerBTruneDR.Otitis media incidence and impact on the auditory brain stem response in lipopolysaccharide-nonresponsive C3H/HeJ mice. Otolaryngol Head Neck Surg. 1997;117:459-464.
61.
BhuttaMFCheesemanMTBrownSD.Myringotomy in the Junbo mouse model of chronic otitis media alleviates inflammation and cellular hypoxia. Laryngoscope. 2014;124:E377-E383.
62.
LysaghtACYuanQFanY. FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice. PLoS One. 2014;9:e107681.
63.
FuchsJCZinnamonFATaylorRR. Hearing loss in a mouse model of 22q11.2 deletion syndrome. PLoS One. 2013;8:e80104.
64.
HempelRJMortonDJSealeTWWhitbyPWStullTL.The role of the RNA chaperone Hfq in Haemophilus influenzae pathogenesis. BMC Microbiol. 2013;13:134.
65.
LaCrossNCMarrsCFGilsdorfJR.Otitis media associated polymorphisms in the hemin receptor HemR of nontypeableHaemophilus influenzae. Infect Genet Evol. 2014;26:47-57.
66.
HarrisonASantanaEASzelesteyBRNewsomDEWhitePMasonKM.Ferric uptake regulator and its role in the pathogenesis of nontypeableHaemophilus influenzae. Infect Immun. 2013;81:1221-1233.
67.
RenDWalkerANDainesDA.Toxin-antitoxin loci vapBC-1 and vapXD contribute to survival and virulence in nontypeableHaemophilus influenzae. BMC Microbiol. 2012;12:263.
68.
RenDKordisAASonenshineDEDainesDA.The ToxAvapA toxin-antitoxin locus contributes to the survival of nontypeable Haemophilus influenzae during infection. PLoS One. 2014;9:e91523.
69.
TongHHLambertGLiYX. Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice. PLoS One. 2014;9:e95160.
70.
WangWZhouAZhangX. Interleukin 17A promotes pneumococcal clearance by recruiting neutrophils and inducing apoptosis through a p38 mitogen-activated protein kinase-dependent mechanism in acute otitis media. Infect Immun. 2014;82:2368-2377.
71.
KirkebySFriisMMikkelsenHBCaye-ThomasenP.Bacterial adherence in otitis media: determination of N-acetylgalactosamine (GalNAc) residues in the submucosal glands and surface epithelium of the normal and diseased Eustachian tube. Microb Pathog. 2011;51:48-57.
72.
KerschnerJEHongWKhampangPJohnstonN.Differential response of gel-forming mucins to pathogenic middle ear bacteria. Int J Pediatr Otorhinolaryngol. 2014;78:1368-1373.
73.
SongJJLeeJDLeeBDChaeSWParkMK.Effect of acrolein, a hazardous air pollutant in smoke, on human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol. 2013;77:1659-1664.
74.
ImGJParkMKSongJJ.Effect of urban particles on human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol. 2014;78:777-781.
75.
ParkMKChaeSWKimHBChoJGSongJJ.Middle ear inflammation of rat induced by urban particles. Int J Pediatr Otorhinolaryngol. 2014;78:2193-2197.
76.
HongSVan KaerL.Immune privilege: keeping an eye on natural killer T cells. J Exp Med. 1999;190:1197-1200.
77.
AlfordBRMcFarlaneJRNeelyJG.Homograft replacement of the tympanic membrane. Laryngoscope. 1976;86:199-208.
78.
LasisiAOOlayemiOArinolaOGOmilabuSA.Interferon-gamma in suppurative otitis media: significance of otorrhoea type and disease outcome. J Laryngol Otol. 2009;123:1103-1107.
79.
SiYZhangZGChenSJ. Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media. Hum Immunol. 2014;75:771-776.
80.
DongHStromeSESalomaoDR. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793-800.
81.
VeselyMDKershawMHSchreiberRDSmythMJ.Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235-271.
82.
ScandiuzziLGhoshKZangX.T cell costimulation and coinhibition: genetics and disease. Discov Med. 2011;12:119-128.
83.
DongHZhuGTamadaKChenL.B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5:1365-1369.
84.
NovotnyLAClementsJDBakaletzLO.Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization. Vaccine. 2013;31:3417-3426.
85.
Luke-MarshallNRMangTSHansenLACampagnariAA.Moraxella catarrhalis is susceptible to antimicrobial photodynamic therapy with Photofrin. Lasers Surg Med. 2014;46:712-717.
86.
WangXFernandezRTsivkovskaiaN. OTO-201: nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media. Otol Neurotol. 2014;35:459-469.
87.
LiCGuJMaoXAoHYangX.Preparation of levofloxacin thermo-sensitive gel and clinical application in the treatment of suppurative otitis media. Acta Otolaryngol. 2014;134:468-474.
